Dorothy Margolskee
InvestorMD at Foresite Capital
New Jersey
Writes $100K – $5M checks · typically $1.5M
Find your path to Dorothy
198 people in our graph share verified history with Dorothy — schools, employers, funds. One of them is your warm intro.
Victoria LewisunlockedDorothy: together at Foresite Capital (2022–2025)
×3Dorothy: together at Foresite Capital
×3Dorothy: together at Harvard University
×3Dorothy: together at The Johns Hopkins University School of Medicine
About
Dorothy Margolskee joined Foresite Capital in 2012, where she has overseen the firm's research and development evaluation group and built an early version of its investment technical review process for analyzing biotechnology portfolios. She previously served as Managing Director in charge of Research at Prospect Ventures, and earlier spent 15 years in drug development at Merck Research Labs, rising to Senior Vice President and contributing to programs including several vaccines and HIV treatments. She holds an M.D. from Johns Hopkins Medical School and a B.A. from Harvard University, and is board certified in Internal Medicine and Pulmonary.
Invests in
Biotech
Experience
- Foresite Capital ManagementManaging Directorcurrent2013 — present
- Prospect Venture PartnersSenior Advisor2011 — 2013
- Prospect Venture PartnersManaging Director2001 — 2011
- Synergee LLCFounder and Principal2001 — 2013
- Merck Research LabsSenior Vice President, Project & Vaccine Integration1999 — 2001
- Merck Research LabsVice President, Project and Vaccine Integration1996 — 1999
- Merck Research LabsExecutive Director, Project Planning and Development1993 — 1996
- Merck Research LabsDirector, Clinical Pharmacology1989 — 1993
- Merck Research LabsAssociate Director, Clinical Pharmacology1987 — 1989
- University of California San FransicoFellow, Pulmonary Medicine1983 — 1987
- Johns Hopkins HospitalResident, Internal Medicine1980 — 1983
Skills & more
Biotechnology14Vaccines8R&D3Venture Capital2Program Management2Lifesciences2Clinical Development7Management1Oncology2Clinical Trials2Drug Development4Biopharmaceuticals3
+11 more
Technology TransferCommercializationDrug DiscoveryCRORegulatory SubmissionsDue DiligencePharmaceutical IndustryBiochemistryGenomicsImmunologyLife SciencesFrom Dorothy's professional profile.
Colleagues at Foresite Capital
Alex M. Azar II
Advisor at Foresite Capital
Amelia Stoj
CCO and Assistant General Counsel at Foresite Capital
Charmaine Villasin
Origination at EVP
Collin Yang-Wong
Principal at Foresite Capital
Cynthia Carpenter
Executive Associate at Foresite Capital
Darren Haggerty
Operations Investment Analyst at Foresite Capital
Deepak Atri
Principal at Foresite Capital
Deepak Atri, MD
Investor at Foresite Capital
Network4
Cindy Xiong
Investor at Foresite Capital
Collin Yang-Wong
Principal at Foresite Capital
Deepak Atri
Principal at Foresite Capital
Dennis Ryan
Managing Director at Foresite Capital
Investors connected to Dorothy in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Dorothy Margolskee?
- Dorothy Margolskee joined Foresite Capital in 2012, where she has overseen the firm's research and development evaluation group and built an early version of its investment technical review process for analyzing biotechnology portfolios. She previously served as Managing Director in charge of Research at Prospect Ventures, and earlier spent 15 years in drug development at Merck Research Labs, rising to Senior Vice President and contributing to programs including several vaccines and HIV treatments. She holds an M.D. from Johns Hopkins Medical School and a B.A. from Harvard University, and is board certified in Internal Medicine and Pulmonary.
- Where does Dorothy Margolskee work?
- Dorothy Margolskee is MD at Foresite Capital.
- What does Dorothy Margolskee invest in?
- Dorothy Margolskee invests in Biotech.
- What check size does Dorothy Margolskee write?
- Dorothy Margolskee typically writes checks of $100K – $5M.
- Where did Dorothy Margolskee go to school?
- Dorothy Margolskee studied at The Johns Hopkins University School of Medicine (MD, Internal Medicine); Harvard University (B.A., Biochemistry and Molecular Biology).
Same school
Also attended The Johns Hopkins University School of Medicine59
Hal PazInvestor at Khosla VenturesRochelle WalenskyExecutive Partner at Flare Capital PartnersBeth SeidenbergFounding Managing Director at Westlake Village BioPartnersStephen P. ZacharyManaging Partner at Sands Capital VenturesS.K. LeeExecutive Coach at Roble VenturesEric HsuAnalyst, Private Equity at Sofinnova Ventures
.png)
+ 53 more
Also attended Harvard University2,000
Ron ConwayFounder of SV AngelAlfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalG
+ 1,994 more
Shared employers
Also worked at Prospect Venture Partners10
Avery CannonChief Administrative Officer at Founders Circle CapitalDave MarklandCFO and Administrative Partner at Tenaya CapitalIlan ZipkinVenture Partner at Breakout VenturesLori SimotasCFO at FloodgateCynthia CarpenterExecutive Associate at Foresite CapitalJim TananbaumFounder & CEO at Foresite Capital
+ 4 more
Also worked at Johns Hopkins Hospital18
Rochelle WalenskyExecutive Partner at Flare Capital PartnersRachel PhilbinVice President at Long Ridge Equity PartnersBrian MullerPrincipal at Black Jays VenturesJarred BressnerPrincipal at Activate Venture PartnersJessica ChaoInvestor at Endurance28Tony HoInvestor at Pivotal Life Sciences
+ 12 more